{"id":327,"date":"2025-03-08T21:43:39","date_gmt":"2025-03-08T21:43:39","guid":{"rendered":"https:\/\/rheumanext.pl\/?page_id=327"},"modified":"2026-03-14T18:31:46","modified_gmt":"2026-03-14T18:31:46","slug":"mieszana-choroba-tkanki-lacznej-mctd-kasukawa","status":"publish","type":"page","link":"https:\/\/rheumanext.pl\/en\/kalkulatory\/kryteria\/mieszana-choroba-tkanki-lacznej-mctd-kasukawa\/","title":{"rendered":"Mieszana choroba tkanki \u0142\u0105cznej (MCTD) &#8211; Kasukawa"},"content":{"rendered":"<section id=\"rx-mctd-kasukawa-calculator\" style=\"max-width:960px;margin:0 auto;font:16px\/1.55 Inter,ui-sans-serif,system-ui,-apple-system,BlinkMacSystemFont,'Segoe UI',sans-serif;color:#0f172a;\">\n  <div style=\"background:linear-gradient(180deg,#ffffff 0%,#fbfdff 100%);border:1px solid #e2e8f0;border-radius:24px;box-shadow:0 12px 30px rgba(15,23,42,.06);overflow:hidden;\">\n    <div style=\"padding:28px 28px 20px;border-bottom:1px solid #e2e8f0;background:radial-gradient(circle at top right, rgba(15,118,110,.08), transparent 32%), linear-gradient(180deg,#ffffff 0%,#f8fafc 100%);\">\n      <div style=\"display:inline-block;padding:6px 12px;border-radius:999px;background:rgba(15,118,110,.10);color:#0f766e;font-size:12px;font-weight:700;letter-spacing:.02em;text-transform:uppercase;margin-bottom:14px;\">Kalkulator klasyfikacyjny<\/div>\n      <h2 style=\"margin:0 0 10px;font-size:clamp(24px,3vw,32px);line-height:1.15;letter-spacing:-.02em;\">Mieszana choroba tkanki \u0142\u0105cznej (MCTD) \u2014 Kasukawa<\/h2>\n      <p style=\"margin:0;color:#475569;max-width:74ch;\">Wymagane s\u0105 dodatnie przeciwcia\u0142a anty-U1 RNP oraz co najmniej 1 objaw wsp\u00f3lny. Nast\u0119pnie potrzebna jest obecno\u015b\u0107 co najmniej 1 cechy z co najmniej 2 z 3 grup: SLE-like, SSc-like i PM-like.<\/p>\n    <\/div>\n\n    <div style=\"padding:28px;display:grid;gap:20px;\">\n      <div style=\"background:#fff;border:1px solid #e2e8f0;border-radius:20px;padding:20px;\">\n        <h3 style=\"margin:0 0 6px;font-size:18px;\">1. Manifestacja immunologiczna<\/h3>\n        <p style=\"margin:0 0 16px;color:#475569;font-size:14px;\">Czy pacjent ma dodatnie przeciwcia\u0142a anty-U1 RNP?<\/p>\n\n        <label style=\"display:flex;align-items:flex-start;gap:10px;padding:12px 14px;border:1px solid #e2e8f0;border-radius:16px;margin-bottom:10px;background:#fff;cursor:pointer;\">\n          <input type=\"radio\" name=\"rx-kasukawa-u1rnp\" id=\"rx-kasukawa-u1rnp-no\" value=\"no\" checked style=\"margin-top:3px;accent-color:#0f766e;\">\n          <span><strong>Nie<\/strong><\/span>\n        <\/label>\n\n        <label style=\"display:flex;align-items:flex-start;gap:10px;padding:12px 14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n          <input type=\"radio\" name=\"rx-kasukawa-u1rnp\" id=\"rx-kasukawa-u1rnp-yes\" value=\"yes\" style=\"margin-top:3px;accent-color:#0f766e;\">\n          <span><strong>Tak<\/strong><\/span>\n        <\/label>\n      <\/div>\n\n      <div style=\"background:#fff;border:1px solid #e2e8f0;border-radius:20px;padding:20px;\">\n        <h3 style=\"margin:0 0 6px;font-size:18px;\">2. Objawy wsp\u00f3lne<\/h3>\n        <p style=\"margin:0 0 16px;color:#475569;font-size:14px;\">Potrzebny jest co najmniej 1 objaw wsp\u00f3lny.<\/p>\n\n        <div style=\"display:grid;grid-template-columns:repeat(auto-fit,minmax(240px,1fr));gap:12px;\">\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-raynaud\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Objaw Raynauda<\/strong><br><span style=\"color:#475569;font-size:13px;\">Raynaud phenomenon<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-swollen\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Obrz\u0119k palc\u00f3w \/ obrz\u0119k r\u0105k<\/strong><br><span style=\"color:#475569;font-size:13px;\">Swollen fingers or hands<\/span><\/span>\n          <\/label>\n        <\/div>\n      <\/div>\n\n      <div style=\"background:#fff;border:1px solid #e2e8f0;border-radius:20px;padding:20px;\">\n        <h3 style=\"margin:0 0 6px;font-size:18px;\">3. Manifestacje mieszane \u2014 SLE-like<\/h3>\n        <p style=\"margin:0 0 16px;color:#475569;font-size:14px;\">Do zaliczenia tej grupy wystarczy co najmniej 1 cecha.<\/p>\n\n        <div style=\"display:grid;grid-template-columns:repeat(auto-fit,minmax(240px,1fr));gap:12px;\">\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-polyarthritis\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Wielostawowe zapalenie staw\u00f3w<\/strong><br><span style=\"color:#475569;font-size:13px;\">Polyarthritis<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-lymphadenopathy\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Limfadenopatia<\/strong><br><span style=\"color:#475569;font-size:13px;\">Lymphadenopathy<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-erythema\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Rumie\u0144 twarzy<\/strong><br><span style=\"color:#475569;font-size:13px;\">Facial erythema<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-serositis\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Zapalenie op\u0142ucnej lub osierdzia<\/strong><br><span style=\"color:#475569;font-size:13px;\">Pericarditis or pleuritis<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;grid-column:1\/-1;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-cytopenia\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Leukopenia lub ma\u0142op\u0142ytkowo\u015b\u0107<\/strong><br><span style=\"color:#475569;font-size:13px;\">Leukopenia or thrombocytopenia<\/span><\/span>\n          <\/label>\n        <\/div>\n      <\/div>\n\n      <div style=\"background:#fff;border:1px solid #e2e8f0;border-radius:20px;padding:20px;\">\n        <h3 style=\"margin:0 0 6px;font-size:18px;\">4. Manifestacje mieszane \u2014 SSc-like<\/h3>\n        <p style=\"margin:0 0 16px;color:#475569;font-size:14px;\">Do zaliczenia tej grupy wystarczy co najmniej 1 cecha.<\/p>\n\n        <div style=\"display:grid;grid-template-columns:repeat(auto-fit,minmax(240px,1fr));gap:12px;\">\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-sclerodactyly\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Sklerodaktylia<\/strong><br><span style=\"color:#475569;font-size:13px;\">Sclerodactyly<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-lung\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>W\u0142\u00f3knienie p\u0142uc \/ restrykcja \/ obni\u017cona dyfuzja<\/strong><br><span style=\"color:#475569;font-size:13px;\">Pulmonary fibrosis, restrictive changes or reduced diffusion capacity<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;grid-column:1\/-1;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-esophagus\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Hipomotoryka lub poszerzenie prze\u0142yku<\/strong><br><span style=\"color:#475569;font-size:13px;\">Hypomotility or dilatation of esophagus<\/span><\/span>\n          <\/label>\n        <\/div>\n      <\/div>\n\n      <div style=\"background:#fff;border:1px solid #e2e8f0;border-radius:20px;padding:20px;\">\n        <h3 style=\"margin:0 0 6px;font-size:18px;\">5. Manifestacje mieszane \u2014 PM-like<\/h3>\n        <p style=\"margin:0 0 16px;color:#475569;font-size:14px;\">Do zaliczenia tej grupy wystarczy co najmniej 1 cecha.<\/p>\n\n        <div style=\"display:grid;grid-template-columns:repeat(auto-fit,minmax(240px,1fr));gap:12px;\">\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-weakness\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Os\u0142abienie mi\u0119\u015bni<\/strong><br><span style=\"color:#475569;font-size:13px;\">Muscle weakness<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-enzymes\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Podwy\u017cszone enzymy mi\u0119\u015bniowe<\/strong><br><span style=\"color:#475569;font-size:13px;\">Elevated muscle enzymes (CPK)<\/span><\/span>\n          <\/label>\n\n          <label style=\"display:flex;align-items:flex-start;gap:10px;padding:14px;border:1px solid #e2e8f0;border-radius:16px;background:#fff;cursor:pointer;grid-column:1\/-1;\">\n            <input type=\"checkbox\" id=\"rx-kasukawa-emg\" style=\"margin-top:3px;accent-color:#0f766e;\">\n            <span><strong>Miogenny zapis EMG<\/strong><br><span style=\"color:#475569;font-size:13px;\">Myogenic pattern on EMG<\/span><\/span>\n          <\/label>\n        <\/div>\n      <\/div>\n\n      <div style=\"display:flex;flex-wrap:wrap;gap:12px;margin-top:2px;\">\n        <button\n          type=\"button\"\n          id=\"rx-kasukawa-calc-btn\"\n          style=\"appearance:none;border:0;border-radius:16px;padding:14px 18px;background:linear-gradient(180deg,#0f766e 0%,#115e59 100%);color:#fff;font:inherit;font-weight:700;cursor:pointer;box-shadow:0 12px 24px rgba(15,118,110,.22);display:inline-flex;align-items:center;justify-content:center;min-width:180px;\"\n        >Oblicz wynik<\/button>\n\n        <button\n          type=\"button\"\n          id=\"rx-kasukawa-clear-btn\"\n          style=\"appearance:none;border:1px solid #cbd5e1;border-radius:16px;padding:14px 18px;background:#fff;color:#0f172a;font:inherit;font-weight:700;cursor:pointer;display:inline-flex;align-items:center;justify-content:center;\"\n        >Wyczy\u015b\u0107<\/button>\n      <\/div>\n\n      <div id=\"rx-kasukawa-result\" style=\"display:block;border-radius:20px;padding:20px;border:1px solid #e2e8f0;background:#f8fafc;\">\n        <p id=\"rx-kasukawa-result-title\" style=\"margin:0 0 8px;font-size:18px;line-height:1.3;font-weight:800;color:#0f172a;\">Wynik pojawi si\u0119 tutaj<\/p>\n        <p id=\"rx-kasukawa-result-text\" style=\"margin:0 0 8px;\">Zaznacz odpowiedzi, a nast\u0119pnie kliknij Oblicz wynik.<\/p>\n        <p id=\"rx-kasukawa-result-note\" style=\"margin:0;color:#475569;font-size:14px;\">Regu\u0142a: dodatnie anty-U1 RNP + co najmniej 1 objaw wsp\u00f3lny + co najmniej 1 cecha z co najmniej 2 z 3 grup: SLE-like, SSc-like, PM-like.<\/p>\n      <\/div>\n\n      <div style=\"border:1px solid #e2e8f0;background:linear-gradient(180deg,#ffffff 0%,#f8fafc 100%);border-radius:18px;padding:16px 18px;color:#475569;font-size:14px;\">\n        <strong style=\"color:#0f172a;\">Uwaga:<\/strong> to narz\u0119dzie wspiera klasyfikacj\u0119 MCTD i nie zast\u0119puje pe\u0142nej oceny klinicznej. Wynik nale\u017cy interpretowa\u0107 w kontek\u015bcie obrazu klinicznego oraz diagnostyki r\u00f3\u017cnicowej. Edukacyjnie. Nie zast\u0119puje konsultacji lekarskiej.\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n\n<script>\n(function () {\n  var calcBtn = document.getElementById('rx-kasukawa-calc-btn');\n  var clearBtn = document.getElementById('rx-kasukawa-clear-btn');\n\n  if (!calcBtn || !clearBtn) return;\n\n  calcBtn.addEventListener('click', function () {\n    var hasU1 = document.getElementById('rx-kasukawa-u1rnp-yes').checked;\n\n    var raynaud = document.getElementById('rx-kasukawa-raynaud').checked;\n    var swollen = document.getElementById('rx-kasukawa-swollen').checked;\n    var hasCommon = raynaud || swollen;\n    var commonList = [];\n    if (raynaud) commonList.push('objaw Raynauda');\n    if (swollen) commonList.push('obrz\u0119k palc\u00f3w \/ r\u0105k');\n\n    var sleItems = [];\n    if (document.getElementById('rx-kasukawa-polyarthritis').checked) sleItems.push('wielostawowe zapalenie staw\u00f3w');\n    if (document.getElementById('rx-kasukawa-lymphadenopathy').checked) sleItems.push('limfadenopatia');\n    if (document.getElementById('rx-kasukawa-erythema').checked) sleItems.push('rumie\u0144 twarzy');\n    if (document.getElementById('rx-kasukawa-serositis').checked) sleItems.push('zapalenie op\u0142ucnej lub osierdzia');\n    if (document.getElementById('rx-kasukawa-cytopenia').checked) sleItems.push('leukopenia lub ma\u0142op\u0142ytkowo\u015b\u0107');\n    var sleGroup = sleItems.length >= 1;\n\n    var sscItems = [];\n    if (document.getElementById('rx-kasukawa-sclerodactyly').checked) sscItems.push('sklerodaktylia');\n    if (document.getElementById('rx-kasukawa-lung').checked) sscItems.push('w\u0142\u00f3knienie p\u0142uc \/ restrykcja \/ obni\u017cona dyfuzja');\n    if (document.getElementById('rx-kasukawa-esophagus').checked) sscItems.push('hipomotoryka lub poszerzenie prze\u0142yku');\n    var sscGroup = sscItems.length >= 1;\n\n    var myoItems = [];\n    if (document.getElementById('rx-kasukawa-weakness').checked) myoItems.push('os\u0142abienie mi\u0119\u015bni');\n    if (document.getElementById('rx-kasukawa-enzymes').checked) myoItems.push('podwy\u017cszone enzymy mi\u0119\u015bniowe');\n    if (document.getElementById('rx-kasukawa-emg').checked) myoItems.push('miogenny zapis EMG');\n    var myoGroup = myoItems.length >= 1;\n\n    var groupCount = (sleGroup ? 1 : 0) + (sscGroup ? 1 : 0) + (myoGroup ? 1 : 0);\n    var groupList = [];\n    if (sleGroup) groupList.push('SLE-like');\n    if (sscGroup) groupList.push('SSc-like');\n    if (myoGroup) groupList.push('PM-like');\n\n    var result = document.getElementById('rx-kasukawa-result');\n    var title = document.getElementById('rx-kasukawa-result-title');\n    var text = document.getElementById('rx-kasukawa-result-text');\n    var note = document.getElementById('rx-kasukawa-result-note');\n\n    result.style.display = 'block';\n\n    if (!hasU1) {\n      result.style.background = '#fef2f2';\n      result.style.border = '1px solid #fecaca';\n      title.style.color = '#991b1b';\n      title.innerHTML = 'Kryteria niespe\u0142nione';\n      text.innerHTML = 'Nie spe\u0142niono wymogu immunologicznego: brak dodatnich przeciwcia\u0142 anty-U1 RNP.';\n      note.innerHTML = 'W kryteriach Kasukawy dodatnie anty-U1 RNP jest warunkiem koniecznym.';\n    } else if (!hasCommon) {\n      result.style.background = '#fef2f2';\n      result.style.border = '1px solid #fecaca';\n      title.style.color = '#991b1b';\n      title.innerHTML = 'Kryteria niespe\u0142nione';\n      text.innerHTML = 'Brakuje objawu wsp\u00f3lnego. Potrzebny jest co najmniej 1 z 2: objaw Raynauda lub obrz\u0119k palc\u00f3w \/ r\u0105k.';\n      note.innerHTML = 'Dodatnie anty-U1 RNP samo nie wystarcza do spe\u0142nienia kryteri\u00f3w Kasukawy.';\n    } else if (groupCount >= 2) {\n      result.style.background = '#f0fdf4';\n      result.style.border = '1px solid #bbf7d0';\n      title.style.color = '#166534';\n      title.innerHTML = 'Kryteria spe\u0142nione';\n      text.innerHTML = 'Spe\u0142niono kryteria Kasukawy dla MCTD.';\n      note.innerHTML = 'Objawy wsp\u00f3lne: ' + commonList.join(', ') + '. Spe\u0142nione grupy: ' + groupList.join(', ') + ' (' + groupCount + '\/3).';\n    } else {\n      result.style.background = '#fffbeb';\n      result.style.border = '1px solid #fde68a';\n      title.style.color = '#92400e';\n      title.innerHTML = 'Kryteria niespe\u0142nione';\n      text.innerHTML = 'Przy dodatnim anty-U1 RNP i obecnym objawie wsp\u00f3lnym zaznaczono cechy tylko z ' + groupCount + ' z 3 wymaganych grup.';\n      note.innerHTML = 'Objawy wsp\u00f3lne: ' + commonList.join(', ') + '. Spe\u0142nione grupy: ' + (groupList.length ? groupList.join(', ') : 'brak') + '. Potrzebne s\u0105 co najmniej 2 grupy spo\u015br\u00f3d: SLE-like, SSc-like, PM-like.';\n    }\n  });\n\n  clearBtn.addEventListener('click', function () {\n    document.getElementById('rx-kasukawa-u1rnp-no').checked = true;\n\n    document.getElementById('rx-kasukawa-raynaud').checked = false;\n    document.getElementById('rx-kasukawa-swollen').checked = false;\n\n    document.getElementById('rx-kasukawa-polyarthritis').checked = false;\n    document.getElementById('rx-kasukawa-lymphadenopathy').checked = false;\n    document.getElementById('rx-kasukawa-erythema').checked = false;\n    document.getElementById('rx-kasukawa-serositis').checked = false;\n    document.getElementById('rx-kasukawa-cytopenia').checked = false;\n\n    document.getElementById('rx-kasukawa-sclerodactyly').checked = false;\n    document.getElementById('rx-kasukawa-lung').checked = false;\n    document.getElementById('rx-kasukawa-esophagus').checked = false;\n\n    document.getElementById('rx-kasukawa-weakness').checked = false;\n    document.getElementById('rx-kasukawa-enzymes').checked = false;\n    document.getElementById('rx-kasukawa-emg').checked = false;\n\n    document.getElementById('rx-kasukawa-result').style.display = 'block';\n    document.getElementById('rx-kasukawa-result').style.background = '#f8fafc';\n    document.getElementById('rx-kasukawa-result').style.border = '1px solid #e2e8f0';\n    document.getElementById('rx-kasukawa-result-title').style.color = '#0f172a';\n    document.getElementById('rx-kasukawa-result-title').innerHTML = 'Wynik pojawi si\u0119 tutaj';\n    document.getElementById('rx-kasukawa-result-text').innerHTML = 'Zaznacz odpowiedzi, a nast\u0119pnie kliknij Oblicz wynik.';\n    document.getElementById('rx-kasukawa-result-note').innerHTML = 'Regu\u0142a: dodatnie anty-U1 RNP + co najmniej 1 objaw wsp\u00f3lny + co najmniej 1 cecha z co najmniej 2 z 3 grup: SLE-like, SSc-like, PM-like.';\n  });\n})();\n<\/script>","protected":false},"excerpt":{"rendered":"<p>Kalkulator klasyfikacyjny Mieszana choroba tkanki \u0142\u0105cznej (MCTD) \u2014 Kasukawa Wymagane s\u0105 dodatnie przeciwcia\u0142a anty-U1 RNP oraz co najmniej 1 objaw wsp\u00f3lny. Nast\u0119pnie potrzebna jest obecno\u015b\u0107 co najmniej 1 cechy z co najmniej 2 z 3 grup: SLE-like, SSc-like i PM-like. 1. Manifestacja immunologiczna Czy pacjent ma dodatnie przeciwcia\u0142a anty-U1 RNP? Nie Tak 2. Objawy wsp\u00f3lne&#8230;<\/p>","protected":false},"author":1,"featured_media":0,"parent":980,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"class_list":["post-327","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/pages\/327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/comments?post=327"}],"version-history":[{"count":3,"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/pages\/327\/revisions"}],"predecessor-version":[{"id":1135,"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/pages\/327\/revisions\/1135"}],"up":[{"embeddable":true,"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/pages\/980"}],"wp:attachment":[{"href":"https:\/\/rheumanext.pl\/en\/wp-json\/wp\/v2\/media?parent=327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}